Alphamab Co. Ltd.
Novel Drug Screening
Protein/Ab Engineering Platform
Process Development

Pipeline: Innovation

  Field H2L L2O PreClin P I
KN057 Hematolo...
KN059 Infectio...
KN043 Infectio...

Pipeline: Biosimilar

  Field L2O PreClin Phase
KN024 Oph.
KN012 Osteo.
Press ReleaseMore>>
KN035 (Envafolimab) Phase IIb HBV C...2020-12-04
Worth to be notedMore>>
The market for type 2 diabetes tre...2015-01-12
Victory against Ebola 'within our r...2015-01-05
HUWE1 Ubiquitylates and D...2015-01-03